The art of innovation: clinical development of trastuzumab deruxtecan and redefining how antibody-drug conjugates target HER2-positive cancers.
作者信息
Yver A, Agatsuma T, Soria J-C
机构信息
Daiichi Sankyo Cancer Enterprise, Daiichi Sankyo, Inc, Basking Ridge, USA.
Oncology Research Laboratories I, R&D Division, Daiichi Sankyo Co, Ltd, Tokyo, Japan.
出版信息
Ann Oncol. 2020 Mar;31(3):430-434. doi: 10.1016/j.annonc.2019.11.019. Epub 2019 Dec 11.
PMID:32067685
Abstract
摘要
Zotero 插件